Search results for Btx

Allergan Aesthetics Receives Positive CHMP Opinion for TrenibotulinumtoxinE for Glabellar Lines

The botulinum neurotoxin type E candidate is designed for a faster onset and shorter duration of effect than currently available neurotoxin treatments.

BTX: A Strategy Reset, A 17% Discount, And Retail Access To Frontier AI

China Approves First Recombinant Botulinum Toxin for Glabellar Lines

The neurotoxin, developed by Claruvis Pharmaceutical, uses a precision-engineered recombinant manufacturing process for botulinum toxin type A.

Ipsen unveils data for Botox rival that drove long-acting anti-wrinkle jab into phase 3

Ipsen has shared phase 2 data on its long-acting neurotoxin, reporting an increase in the proportion of people with significant improvements in frown lines 24 weeks after treatment...

<![CDATA[FDA Issues CRL to AbbVie for TrenibotulinumtoxinE’s Biologics License Application ]]>

BTX Precision Announces Acquisition of Maitland Engineering

-Expanding its Precision Components Manufacturing Platform

FDA Issues Complete Response Letter for AbbVie’s Fast-Acting Toxin Application

Agency requests additional manufacturing information and does not cite safety or efficacy concerns or require new clinical studies.